We partner with 503B compounding pharmacies across The United States to provide you with the highest-quality compounded solutions for IM and IV administration. We have listed just a few of the many things they offer, see below!

Outsourcing facilities are sometimes referred to as 503B facilities because 503B refers to the filling of “office use” or “office administered” medications. The FDA created this new designation of compounding pharmacy to establish a new level of patient care, safety, and guidelines. Outsourcing facilities must comply with strict cGMP (current good manufacturing practices) which are the same standards and guidelines that pharmaceutical manufacturers follow. The outsourcing facilities are now the ONLY pharmacies permitted, under the new law, to provide compounded medications for use in physicians’ offices, clinics, and hospitals.

•  Must comply with CGMP requirements.
•  Are inspected by FDA according to a risk-based schedule.
•  Must meet certain other conditions, such as reporting adverse events and providing FDA with certain information about the products they compound.
•  503B outsourcing facilities may manufacture for office use.
•  Frequent Monitoring: Environmental monitoring must be performed per production shift in primary compounding areas and weekly in secondary compounding areas.
•  Quality Control: 503B outsourcing facilities are required to maintain their own quality department as its own autonomous entity to conduct investigations.

•  B-12 Cyanocobalamin – Testosterone – Dexamethasone – Methylprednisolone (Depo Medrol)
•  Lipotropics/MIC B-12 – Weight Loss Program
•  Betamethasone - Kenalog - Progesterone - Sodium Chloride
•  and more!

Committed to Excellence

Injections, IV therapy and Controlled Pills/Tablets are sold to Doctors & Clinics ONLY. We also offer OTC products for Individuals, Wholesalers, and Doctors/Clinics. For more information on our OTC products visit our OTC website.